We show that in CLL cells, IL-4-induced upregulation of Jag1 protein is mediated by the PI3Kδ/AKT pathway, an important therapeutic target in this leukemia49–52. This evidence concerns the gene AKT1 and B-cell chronic lymphocytic leukemia.